Ian Mortimer, CEO of Xenon Pharmaceuticals Inc., sold 40,000 shares on January 2nd at an average price of $44.43 per share, bringing the total transaction value to $1,777,200. After this sale, Mr. Mor...

Eric Venker, CEO of Roivant Sciences Ltd., sold 75,000 shares at an average price of $22.53 per share on December 24th, totalling $1,689,750 in transactions. Post this sale, Venker directly owns 1,654...

Matthew Klein, the CEO of PTC Therapeutics (NASDAQ: PTCT), sold 2,514 shares on January 8th at an average price of $76.45 per share, totaling approximately $192,195.30. Post transaction, he directly o...

CeriBell Inc.'s CEO, Xingjuan Chao, sold 79,000 shares on January 5th at an average price of $21.27 per share, totalling a sale value of approximately $1,680,330. She currently holds 741,248 shares di...